Home > Food & Beverages > Nutraceuticals > Lactase Market

Lactase Market Share

  • Report ID: GMI7934
  • Published Date: Jan 2024
  • Report Format: PDF

Lactase Market Share

In the highly competitive lactase industry, several key players have emerged as industry leaders, playing a pivotal role in shaping the landscape of lactase production and distribution. Lactose India Limited stands out as a prominent market player, leveraging its extensive expertise in lactase manufacturing. The company's commitment to quality and innovation has contributed significantly to its market prominence. Additionally, DFE Pharma has carved a niche for itself with a focus on providing high-quality lactase products for pharmaceutical and food industries. Their strategic partnerships and investments in research and development have fortified their position as a major contributor to the market.
 

Armor Pharma, another noteworthy player, has established itself as a reliable supplier of lactase for pharmaceutical applications, emphasizing pharmaceutical-grade lactase production. This dedication to meeting the stringent standards of the pharmaceutical industry has earned Armor Pharma a distinguished position in the market. Furthermore, Valio Ltd., with its global presence, has become a key player in the lactase market, offering a diverse range of lactase products. The company's emphasis on sustainable and ethical practices in lactase production aligns with evolving consumer preferences, contributing to its market influence. Together, these top market players exemplify the dynamic and competitive nature of the market, each bringing unique strengths and innovations to meet the growing demand for lactase worldwide.
 

Lactase Market Companies

Major companies operating in the lactase industry include:

  • Amano Enzyme Inc.
  • Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
  • Armor Pharma
  • BASF SE
  • Chr. Hansen Holding A/S
  • DFE Pharma
  • DSM Nutritional Products
  • Kerry Group Plc
  • Lactose India Limited
  • Meggle Excipients & Technology
  • Merck & Co., KgAa
  • Novozymes A/S
  • Valio Ltd.
Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of lactase reached USD 1.23 billion in revenue in 2023 and is set to be worth USD 2.13 billion by 2032, attributed to the growing prevalence of lactose intolerance worldwide coupled with rising consumer awareness of digestive health.

Animal-derived lactase segment generated USD 86.5 million in 2023, owing to the growing consumer demand for alternatives to traditional dairy due to lactose intolerance, digestive concerns, or dietary preferences.

U.S. market was valued at USD 64.6 million in revenue in 2023, driven by the robust dairy sector, heightened consumer awareness about lactose intolerance, and the booming demand for lactose-free products.

Some of the top lactase firms are BASF SE, Amano Enzyme Inc., Armor Pharma, Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, Merck & Co., KgAa, Chr. Hansen Holding A/S, DSM Nutritional Products, Kerry Group Plc, Lactose India Limited, Meggle Excipients & Technology, Novozymes A/S, and Valio Ltd.

Lactase Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 203
  • Countries covered: 21
  • Pages: 180
 Download Free Sample